Jeffrey A Allen

Associate Professor, Neurology

Emailjaallen@umn.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Finished
5 Active

Long -Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)
Bellin, M. D., Allen, J. A., Beilman, G. J., Drawz, P. E., Koozekanani, D. & Van't Hof, J. R.
NIH Natl Inst of Diabetes/Dig/Kidney Dis
1/15/21 → 12/31/25
Project: Research project
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10%(Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion(Human), 10% (GAMMAGARD LIQUID/KIOVIG)
Allen, J. A.
Baxalta US Inc.
11/14/19 → 5/31/22
Project: Research project
A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects with Guillain-Barre Syndrome
Allen, J. A.
ANNEXON, INC
10/1/19 → 9/30/22
Project: Research project
A Phase 3, Multicenter, Randomized,Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy ofZilucoplan in Subjects with Generalized Myasthenia Gravis
Allen, J. A.
RA PHARMACEUTICALS, INC
8/1/19 → 7/31/23
Project: Research project
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-2401 in MyastheniaGravis Patients
Allen, J. A.
IMMUNOVANT, INC.
1/1/19 → 12/31/21
Project: Research project

32 Article
8 Review article
4 Chapter
2 Letter
More
- 1 Comment/debate
- 1 Editorial

A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
Allen, J. A., Butler, L., Levine, T. & Haudrich, A., Jan 2021, In: Advances in Therapy. 38, 1, p. 316-328 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Correction to: A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (Advances in Therapy, (2021), 38, 1, (316-328), 10.1007/s12325-020-01540-6)
Allen, J. A., Butler, L., Levine, T. & Haudrich, A., Feb 2021, In: Advances in Therapy. 38, 2, p. 1364-1367 4 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor
the VM202 study group, 2021, (Accepted/In press) In: Clinical and translational science.
Research output: Contribution to journal › Article › peer-review

Open Access
Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy
Broers, M. C., Bunschoten, C., Drenthen, J., Beck, T. A. O., Brusse, E., Lingsma, H. F., Allen, J. A., Lewis, R. A., van Doorn, P. A. & Jacobs, B. C., Mar 3 2021, (E-pub ahead of print) In: European Journal of Neurology.
Research output: Contribution to journal › Article › peer-review

Open Access
Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study
Allen, J. A., Pasnoor, M., Dimachkie, M. M., Ajroud-Driss, S., Brannagan, T. H., Cook, A. A., Walton, T., Fiecas, M. B., Kissel, J. T., Merkies, I., Gorson, K. C. & Lewis, R. A., Apr 6 2021, In: Neurology. 96, 14, p. e1876-e1886
Research output: Contribution to journal › Article › peer-review